Search research articles
Contact Us
Filters
Showing results (241-250 of 377) with videos related to
Page
of 38
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2014
Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia
Stefan Hitz, Cornelia Habekost, Sebastian Fürst, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 16, 2026
Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization
Lisa Steinhelfer, Friederike Jungmann, Lukas Endroes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 4, 2026
AI-based tumor and organ volumetry predicts early progression after Y-90 radioembolization in liver-dominant metastatic disease
Daniel Martinez Heinemann, Jannis Bodden, Lukas Endroes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 3, 2013
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer
Michael Souvatzoglou, Matthias Eiber, Toshiki Takei, et al.
Asian Journal of Urology
|
February 24, 2022
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
Christa Babst, Thomas Amiel, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
Andrea Farolfi, Nader Hirmas, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 7, 2021
Whole-body uptake classification and prostate cancer staging in <sup>68</sup>Ga-PSMA-11 PET/CT using dual-tracer learning
Nicolò Capobianco, Ludovic Sibille, Maythinee Chantadisai, et al.
Oncotarget
|
August 31, 2016
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
Sarah M Schwarzenböck, Anna Knieling, Michael Souvatzoglou, et al.
Radiology
|
July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
European Urology
|
November 27, 2018
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with <sup>177</sup>Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
Matthias M Heck, Robert Tauber, Sebastian Schwaiger, et al.
Page
of 38
Search research articles
Search
Showing results (241-250 of 377) with videos related to
Sort By:
Page
of 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 17, 2014
Systematic Comparison of the Performance of Integrated Whole-Body PET/MR Imaging to Conventional PET/CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia
Stefan Hitz, Cornelia Habekost, Sebastian Fürst, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 16, 2026
Fully automated spleen segmentation predicts progression-free survival in HCC patients following transarterial radioembolization
Lisa Steinhelfer, Friederike Jungmann, Lukas Endroes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 4, 2026
AI-based tumor and organ volumetry predicts early progression after Y-90 radioembolization in liver-dominant metastatic disease
Daniel Martinez Heinemann, Jannis Bodden, Lukas Endroes, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 3, 2013
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer
Michael Souvatzoglou, Matthias Eiber, Toshiki Takei, et al.
Asian Journal of Urology
|
February 24, 2022
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
Christa Babst, Thomas Amiel, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 12, 2020
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
Andrea Farolfi, Nader Hirmas, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 7, 2021
Whole-body uptake classification and prostate cancer staging in <sup>68</sup>Ga-PSMA-11 PET/CT using dual-tracer learning
Nicolò Capobianco, Ludovic Sibille, Maythinee Chantadisai, et al.
Oncotarget
|
August 31, 2016
[11C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
Sarah M Schwarzenböck, Anna Knieling, Michael Souvatzoglou, et al.
Radiology
|
July 11, 2023
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer
Andrei Gafita, Loïc Djaileb, Isabel Rauscher, et al.
European Urology
|
November 27, 2018
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with <sup>177</sup>Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
Matthias M Heck, Robert Tauber, Sebastian Schwaiger, et al.
Page
of 38